Literature DB >> 12817192

Gender differences in left ventricular chamber and midwall systolic function in normotensive and hypertensive adults.

Aldo Celentano1, Vittorio Palmieri, Emma Arezzi, Gian Francesco Mureddu, Maria Sabatella, Giovanni Di Minno, Giovanni De Simone.   

Abstract

OBJECTIVE: Whether left ventricular (LV) systolic function differs between healthy men and women independent of afterload, LV geometry, age, heart rate and body size is disputed.
METHODS: We studied 517 clinically healthy adults without history of cardiovascular or endocrinal disease (age range 20-70, 274 with essential arterial hypertension). Echocardiography was used to assess LV geometry and systolic function both at endocardial and midwall levels.
RESULTS: Normotensive and hypertensive women had higher LV systolic function at endocardial and midwall levels independent of afterload. After adjustment for age, body surface area, heart rate and LV geometry, LV systolic function remained higher in women than in men in hypertensive and normotensive subjects. In a second set of multivariate analyses adjusting for age, body mass index, LV geometry and heart rate, women had significantly higher LV systolic function than men, both among normotensive and hypertensive subjects. In a reference group of 95 subjects with optimal blood pressure and normal body mass index (mean age 34 +/- 10; 32 men) extracted from the study sample, lower limits (5th percentile) of parameters of LV systolic function were higher in women than in men. Use of gender-specific partition values revealed that subnormal LV chamber function was uncommon in overweight, normotensive subjects as well as in hypertensive subjects; vice versa, stress-corrected midwall dysfunction was frequently subnormal in both normotensive, overweight (14%, mostly women) and in hypertensive subjects (18%, mostly men). At the opposite end of the spectrum, gender-specific supranormal, stress-corrected LV systolic chamber function (> 95th percentile of the distribution in the reference group) was relatively frequent in both overweight, normotensive (14%) and in hypertensive subjects (27%).
CONCLUSIONS: Clinically healthy hypertensive and normotensive women have higher LV chamber and midwall systolic function than men, independent of left ventricular geometry, body size, age and heart rate. Use of gender-specific partition values to define subnormal and supranormal LV systolic function revealed that, both in hypertensive and overweight normotensive subjects, subnormal LV chamber function was uncommon, whereas stress-corrected LV chamber systolic function was frequently supranormal. Vice versa, myocardial contractility was subnormal in approximately one-sixth of asymptomatic, normotensive overweight and of hypertensive subjects, with potentially unfavorable prognostic impact.

Entities:  

Mesh:

Year:  2003        PMID: 12817192     DOI: 10.1097/00004872-200307000-00033

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  13 in total

1.  Global Longitudinal Strain by Echocardiography Predicts Long-Term Risk of Cardiovascular Morbidity and Mortality in a Low-Risk General Population: The Copenhagen City Heart Study.

Authors:  Tor Biering-Sørensen; Sofie Reumert Biering-Sørensen; Flemming Javier Olsen; Morten Sengeløv; Peter Godsk Jørgensen; Rasmus Mogelvang; Amil M Shah; Jan Skov Jensen
Journal:  Circ Cardiovasc Imaging       Date:  2017-03       Impact factor: 7.792

2.  Forward and backward wave morphology and central pressure augmentation in men and women in the Framingham Heart Study.

Authors:  Alyssa A Torjesen; Na Wang; Martin G Larson; Naomi M Hamburg; Joseph A Vita; Daniel Levy; Emelia J Benjamin; Ramachandran S Vasan; Gary F Mitchell
Journal:  Hypertension       Date:  2014-08       Impact factor: 10.190

3.  Sex differences in baroreflex sensitivity, heart rate variability, and end organ damage in the TGR(mRen2)27 rat.

Authors:  Megan S Johnson; Vincent G DeMarco; Cheryl M Heesch; Adam T Whaley-Connell; Rebecca I Schneider; Nathan T Rehmer; Roger D Tilmon; Carlos M Ferrario; James R Sowers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-05       Impact factor: 4.733

4.  Gender specific pattern of left ventricular cardiac adaptation to hypertension and obesity in a tertiary health facility in Nigeria.

Authors:  A A Akintunde; Y Oladosu; O G Opadijo
Journal:  Afr Health Sci       Date:  2013-09       Impact factor: 0.927

5.  Stress reduces diastolic function in youth.

Authors:  Gaston K Kapuku; Harry Davis; Kenneth Murdison; Vincent Robinson; Gregory Harshfield
Journal:  Psychosom Med       Date:  2012-06-28       Impact factor: 4.312

6.  Systematic Review and Regression Modeling of the Effects of Age, Body Size, and Exercise on Cardiovascular Parameters in Healthy Adults.

Authors:  Aseem Pradhan; John Scaringi; Patrick Gerard; Ross Arena; Jonathan Myers; Leonard A Kaminsky; Ethan Kung
Journal:  Cardiovasc Eng Technol       Date:  2021-10-19       Impact factor: 2.305

7.  Gender differences in diastolic function among youth.

Authors:  G K Kapuku; H C Davis; N Shah; A M McMillan; G A Harshfield
Journal:  Pediatr Cardiol       Date:  2007-09-25       Impact factor: 1.655

Review 8.  Sex Differences in Cardiovascular Aging and Heart Failure.

Authors:  Andrew Oneglia; Michael D Nelson; C Noel Bairey Merz
Journal:  Curr Heart Fail Rep       Date:  2020-09-28

9.  Sex Difference in the Association Between Brachial Pulse Pressure and Coronary Artery Disease: The Korean Women's Chest Pain Registry (KoROSE).

Authors:  Hack-Lyoung Kim; Myung-A Kim; Wan-Joo Shim; Sohee Oh; Mina Kim; Seong Mi Park; Yong Hyun Kim; Jin Oh Na; Mi Seung Shin; Hyun Ju Yoon; Gil Ja Shin; Yunkyung Cho; Sung-Eun Kim; Kyung-Soon Hong; Kyoung Im Cho
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-07-01       Impact factor: 3.738

Review 10.  Should there be sex-specific criteria for the diagnosis and treatment of heart failure?

Authors:  Lawrence E Greiten; Sara J Holditch; Shivaram Poigai Arunachalam; Virginia M Miller
Journal:  J Cardiovasc Transl Res       Date:  2013-11-09       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.